A detailed history of Crewe Advisors LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Crewe Advisors LLC holds 93 shares of WST stock, worth $27,574. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93
Previous 22 322.73%
Holding current value
$27,574
Previous $8,000 275.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$314.68 - $395.94 $22,342 - $28,111
71 Added 322.73%
93 $30,000
Q1 2024

May 13, 2024

BUY
$338.27 - $413.0 $7,441 - $9,086
22 New
22 $8,000
Q2 2023

Jul 28, 2023

SELL
$334.63 - $382.47 $20,077 - $22,948
-60 Reduced 92.31%
5 $1,000
Q4 2022

Feb 07, 2023

BUY
$209.34 - $261.61 $11,304 - $14,126
54 Added 490.91%
65 $15,000
Q3 2022

Nov 14, 2022

BUY
$246.08 - $343.65 $2,706 - $3,780
11 New
11 $3,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $22B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.